Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiencyReport as inadecuate




Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency - Download this document for free, or read online. Document in PDF available to download.

Osteoporosis International

, Volume 23, Issue 8, pp 2219–2226

First Online: 29 November 2011Received: 11 August 2011Accepted: 26 October 2011

Abstract

SummaryGrowth hormone GH treatment in young adults with childhood-onset GH deficiency has beneficial effects on bone mass. The present study shows that cortical bone dimensions also benefit from GH treatment, with endosteal expansion and increased cortical thickness leading to improved bone strength.

IntroductionIn young adults with childhood-onset growth hormone deficiency CO GHD, GH treatment after final height is reached has been shown to have beneficial effects on spine and hip bone mineral density. The objective of the study was to evaluate the influence of GH on cortical bone dimensions.

MethodsPatients n = 160; mean age, 21.2 years; 63% males with CO GHD were randomised 2:1 to GH or no treatment for 24 months. Cortical bone dimensions were evaluated by digital x-ray radiogrammetry of the metacarpal bones every 6 months.

ResultsAfter 24 months, cortical thickness was increased compared with the controls 6.43%, CI 3.34 to 9.61%; p = 0.0001 and metacarpal index MCI 6.14%, CI 3.95 to 8.38%; p < 0.0001, while the endosteal diameter decreased −4.64%, CI −7.15 to −2.05; p < 0.001. Total bone width did not change significantly 0.68%, CI −1.17 to 2.57%; not significant NS. A gender effect was seen on bone width p < 0.0001, endosteal diameter p < 0.01 and cortical thickness p < 0.01, but not with MCI NS.

ConclusionsCortical bone reacts promptly to reinstitution of GH beyond the attainment of final height by increasing the cortical thickness through endosteal bone growth. This leads to a higher peak bone mass and may reduce the risk of cortical bone fragility later in life.

KeywordsBone strength Cortical bone Growth hormone deficiency Growth hormone treatment Metacarpal index  Download fulltext PDF



Author: L. Hyldstrup - G. S. Conway - K. Racz - A. Keller - P. Chanson - M. Zacharin - A. L. Lysgaard - A. H. Andreasen - A.-M.

Source: https://link.springer.com/







Related documents